Johnson & Johnson To Pay Compensation For Faulty Implants Following Government Order(Photo by Justin Sullivan/Getty Images)

U S healthcare company Johnson & Johnson (J&J) has agreed to compensate patients who have suffered from artificial hip implants, reports Reuters.

A government panel recommended that J&J pay compensation of at least Rs 2 million ($27,812) to each patient who received an ASR hip implant in India. An estimated 4,700 people have undergone the procedure. The central government has asked states to help patients get relief soon.

“We have always been and continue to be fully committed to supporting all ASR patients in India, and the rest of the world,” a J&J spokeswoman said in a statement emailed to Reuters.

“In light of the recent committee report, we are seeking to work with the Indian government to develop an appropriate process for providing further support and compensation for patients in need,” she added.

J&J ASR hip implants were recalled in 2010 after data suggested they failed at a higher-than-expected rate.

The company had already paid $2 million to patients for repeat surgeries and about $250,000 in related diagnostic costs under its ASR reimbursement programme, but came under criticism from the government panel for not offering compensation.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement